As a doctor, she insists on putting people first. In her medical work, she has always been strict with herself in improving her skills, patients as family members, and always patient-centered. She regards continuously improving her medical technology and service level as her medical guide. "In our work, we not bear responsibility andundertake;, but also the trust and love of the people. Medical workers are hardworking, but at the same time, they have noble virtues and heart of a savior." said Duan Ping.

Make one's first appearance

 In September 1983, Duan Ping entered Huaxi Medical University with her dreams. Duan Ping said, "Every of study was like opening a door, the mysteries of medicine unfolded before my eyes, anatomy let me understand the structure of the human body, internal medicine, surgery other professional courses continuously increased my understanding of disease diagnosis and treatment, and the study of various sciences further deepened my understanding of the practical operations of common disease diagnosis treatment." With full confidence and anticipation for the future, Duan Ping stepped into her working position.

Her medical journey

In May 1995, Duan Ping came to work at the Department of Oncology, the First People's Hospital ofdu. "This unfamiliar and profound specialty made me feel timid for the first time. Every patient's condition seemed to be far away from the textbooks. Even after through the books, I didn't know how to handle it. Every day after work, I would study until late at night," said Duan Ping. In to systematically learn about oncology diagnosis and treatment, in March 1996, Duan Ping began her advanced studies at the Cancer Center of Huax Hospital. During this period, she not only gained a deeper understanding and knowledge of oncology diagnosis and treatment, but also successfully published her first paper, "Oansetron Improved Scheme for the Treatment of Nausea and Vomiting Caused by Cisplatin-based Combination Chemotherapy," in the Journal of Oncology. After returning to her department, she applied what she had learned to her actual work, and through the implementation of a series of specialized technologies, theology department transformed from solely palliative treatment to specialized anti-tumor treatment.

In several years of work, Duan Ping gradually discovered the unique auxiliary role of traditional Chinese medicine in tumor treatment. In order to better treatment results to patients, Duan Ping went to Chengdu University of Traditional Chinese Medicine for further study in September 1998, and obtained a's degree after three years. She conducted explorations of integrated traditional Chinese and Western medicine techniques in her department. In December 1999, the paper wrote, "Clinical efficacy analysis of electro-acupuncture treatment for leukopenia caused by chemotherapy", was presented at the Southwest Society of Integrated Traditional Chinese and Western Medicineology. She has also made continuous efforts in scientific research. From October 2000 to March 2001, she participated in the new clinical research (verification) "Shengxue Tiaoyuan Decoction for treating both qi and blood deficiency" initiated by Chengdu University of Traditional Medicine, serving as the research secretary, responsible for case inclusion and data collection and organization. In September 2001, her research project "Comparison of function in lung cancer patients with and without depressive mood disorders" was approved by the Youth Fund of the Chengdu Health Bureau, and was completed on schedule. The was published in "Sichuan Tumor Prevention and Treatment".

Humanity and Benevolence; Patient First

In January 2005, Duan Ping took over as head of the oncology department. In order to provide better services to patients and help them have a correct understanding of cancer, she set up information boards on cancer diagnosis and treatment in the outpatient clinic and wards, organized doctors from the department to give lectures on cancer prevention and treatment in the hospital's outpatient hall in turn, and, on weekends, went into communities with her colleagues to give lectures and provide free medical services. She also recorded and broadcasted lectures on cancer prevention and treatment through various media such as Chengdu Radio, Chengdu TV, and Chengdu Business Daily.

In the field of minimally invasive interventional diagnosis and treatment, under the leadership of Duan Ping, the team has made great efforts and achieved many milestones. The department has completed its first interventional surgery, introduced the technique of alcohol injection into liver cancer tumors without water, B-ultrasound-guided percutaneous biopsy of superficial masses, and biopsy of internal organs such as the liver, kidneys, pancreas, and pelvic masses. The team has also introduced liver cancer tumor chemical ablation with ethanol without water, percutaneous transhepatic biliary drainage, percutaneous lung biopsy, and other minimally invasive interventional techniques. The department has also pioneered the use of interventional techniques such as intravascular interventional therapy and tumor radiofrequency ablation, vertebroplasty and bone augmentation, and radioactive particle implantation in the tumor department of a municipal hospital in Chengdu, greatly improving the level of cancer diagnosis and treatment.

Never forget your original aspiration and press on steadfastly.

Duan Ping said, "Only with technology is not enough, and the support of equipment is needed for the department to further develop." In July 2007, the department purchased its first large-scale equipment since its establishment - a high-frequency tumor hyperthermia machine, and was the first to carry out deep tumor hyperthermia technology in the oncology department of Chengdu municipal hospitals. The development of oncology cannot be separated from radiotherapy technology. From December 2012 to June 2013, Duan Ping began to study radiotherapy technology at the Radiotherapy Center of Sichuan Cancer Hospital; In February 2013, our hospital's first Varian medical linear accelerator was put into use, which can carry out two-dimensional radiotherapy, three-dimensional conformal radiotherapy, and three-dimensional conformal intensity-modulated radiotherapy for tumors; In June 2014, the department opened a biology laboratory and initiated the application of DC/CIK cell therapy in tumor treatment. At this point, our oncology department has launched a comprehensive application of tumor diagnosis and treatment technology in a diagnosis and treatment model, and is a oncology department with significant equipment advantages, talent advantages, technological advantages, and service advantages among the "third grade A" hospitals in the province.

 As the clinical work of the department continues to improve, radiotherapy, medical oncology, interventional minimally invasive techniques and integrated traditional Chinese and Western medicine have been continuously developed. Duan Ping realized the complexity of tumor diagnosis and treatment, and determined that developing a scientific, standardized and optimal treatment plan for patients could effectively improve the cure rate of tumor patients and improve the quality of life for patients. In January 2019, collaborated with Jiang Qing, director of the thoracic surgery department, Song Nian, director of the gastrointestinal surgery department, Lin Wei, director of the radiology, and Zhao Chun, director of the pathology department, to form a multi-disciplinary team (MDT) for thoracic and abdominal tumors, insisting on conductingDT activities every week, and won the "Excellent MDT Team" award on Doctor's Day in 2021 and 2022. In to further expand the department's reputation and enhance its competitiveness, in March 2021, Duan Ping established the Chengdu Hi-tech Zone Tumor Quality Control Sub-center, serving as the director of the sub-center. In November 2021, she also formed the Chengdu Hi-tech Medical Associationumor Interventional Minimally Invasive Professional Committee and the Venous Therapy Nursing Group, serving as the director of the committee. Relying on these two, the hospital launched the creation of demonstration units for standardized cancer pain treatment in primary medical institutions in the Hi-tech Zone, held more than 60 training lectures standardized cancer pain treatment and basic knowledge of tumor diagnosis and treatment, and more than 50 sessions on research capability training, greatly improving the professional technical level and capability of primary medical institution staff. In the 2023 annual assessment of the Chengdu Tumor Disease Quality Control Center, it was rated as anExcellent Quality Control Sub-center".

The development of the department has further highlighted the importance of scientific research. In March 2022, Duan Ping went to the Trial Research Center of Huaxi Hospital for further study and obtained the GCP study PI qualification. On July 28, 2022, hospital's first clinical trial research project was launched: "A single-arm, open, multi-center phase II clinical study to evaluate the efficacy and safety of HLX7 (recombinant humanized anti-EGFR monoclonal antibody injection) monotherapy in patients with locally advanced or metastatic cutaneous squamous carcinoma (CSCC)". This signifies that the medical level and research capabilities of the department have reached a new height.

Her honor

In November 2014, he was rated as one of the "Top Ten Good Doctors" in the second edition "Skilled Hands and Benevolent Hearts: Chengdu's Good Doctors' Reputation List" by Chengdu Business Daily. In August 2015, was awarded the title of "Sichuan's Good Doctor" in the first "Sichuan's Good Doctors·Chengdu" selection event in 015. In August 2019, he was rated as an "Excellent Doctor" at the "Second Chinese Doctors' Day" commendation in Chengdu Hi-tech Industrial Development Zone. In September 2019, he was awarded the title of "Good Doctor" on the "Chinese Doctors Day" by Chengdu Traditional Chinese and Western Medicine Hospital in 2019. In September 2019, he was awarded the title ofTop Ten Famous Doctors" in the seventh "Model China·My Ideal Doctor" large-scale public welfare selection event. In July 2020, he was the title of "Advanced Individual" in the third batch of the fight against the novel coronavirus pneumonia. In January 2022, due to his outstanding in 2020, he was approved and registered as a reward personnel of the direct public institution of the Chengdu Health Commission in 202, and was given a commendation. His department's honors include being designated as a "Key Tumor Specialty of Sichuan Province" by the Sich Administration of Traditional Chinese Medicine in 2013, one of the first "Demonstration Wards for Standardized Cancer Pain Treatment" in Sichuan in 2014, the "Best Clinical Specialty in Tumor Department of Chinese Hospitals in 2020" (ranked by Guangzhouili Hospital), a "Key Medical Discipline (Oncology) in Chengdu" in June 2021, a "National Demonstration Base forized Diagnosis and Treatment of Difficult Pain" in July 2021, a "National Advantage Specialty in Traditional Chinese Medicine (Oncology)" in 023, and a "National Demonstration Ward for Standardized Management of CINV (No Vomiting Ward)" in 2024